2026/0159 - Invitation for Proposals under Framework Agreements 961/2024 - Various Medicines, 2025/1627 - Cardiovascular System Medicines, 900/2024 - Antiretroviral Medicines for HIV Treatment, 899/2024 - Respiratory System Medicines, 780/2024 – Musculoskeletal System Medicines, used in the treatment of endocrine diseases and hormones, 491/2023 - Oncological and Immunomodulatory Medicines, 492/2023 - Anti-infective Medicines
About This Opportunity
TranslatedThis tender, reference 2026/0159, is an invitation for proposals to supply a wide range of pharmaceutical products under several existing framework agreements. The procurement covers multiple therapeutic areas, indicating a comprehensive need for medications. Specifically, it includes 'Various Medicines' (961/2024), 'Cardiovascular System Medicines' (2025/1627), 'Antiretroviral Medicines for HIV Treatment' (900/2024), 'Respiratory System Medicines' (899/2024), 'Musculoskeletal System Medicines' used for endocrine and hormonal treatments (780/2024), 'Oncological and Immunomodulatory Medicines' (491/2023), and 'Anti-infective Medicines' (492/2023). This suggests a large-scale procurement by a public health institution or government agency responsible for supplying medicines to healthcare facilities or the general population. Bidders are invited to submit proposals based on the specifications and conditions outlined in these framework agreements. The objective is to ensure the availability of essential and specialized medicines across various critical medical fields, thereby supporting public health services and patient treatment needs.
This is a supplies contract in the health and medical services, information and communication technology and trade and industry sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 809.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified as 2026/0159, represents an invitation for proposals under existing framework agreements for the supply of various pharmaceutical products in Portugal. The contracting authority, operating within Portugal's public procurement framework, is seeking to procure a range of medicinal items. Specifically, this procurement will draw upon the provisions of framework agreements 961/2024 for Diverse Medicines, 2025/1627 for Cardiovascular System Medicines, and 900/2024 for Antiretroviral Medicines.
The objective is to secure reliable and cost-effective access to a broad spectrum of pharmaceuticals essential for public healthcare services. Suppliers are expected to demonstrate their capacity to meet the demand for these specified medication categories, adhering to stringent quality standards and regulatory requirements applicable within the European Union and Portugal. Typical requirements for such tenders include proven experience in pharmaceutical supply chain management, adherence to Good Distribution Practices (GDP), robust quality assurance systems, and the ability to provide detailed product specifications and certifications. Bidders will likely need to present comprehensive commercial proposals, including pricing, delivery timelines, and evidence of compliance with all relevant pharmaceutical and procurement regulations. This initiative aims to ensure the continuity and quality of medical treatment for the Portuguese population by leveraging established supply agreements.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 11, 2026. Last refreshed 9 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde da Região de Leiria, E. P. E.
Unidade Local de Saúde da Região de Leiria, E. P. E. has issued 578 procurement notices on BidsFactory, including 1 currently open and 553 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to OVERPHARMA - PROD. MÉDICOS E FARMACÊUTICOS, LDA.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde da Região de Leiria, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €809. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.